Complete a short questionnaire Describe your weight history, health and goals online
Genetic testing examines predispositions in GLP-1 pathway genes, which may provide context for expected weight-loss range, medication tolerance, and personalized dosing
In recent years, extensive literature has reported that a variety of signaling pathways and transcription factors are involved in the fat differentiation process of WAT, such as the NOS pathway, neuropeptide S [87] pathway, SIRT1 [88] pathway, STAT3 [89], bone morphogenetic protein 4 (BMP4) [90] pathway, etc
Accessibility and administration considerations Transdermal patches can be an ideal choice for patients with needle anxiety or injection administration issues
Ensure adequate protein intake (generally 0.8-1.0 grams per kilogram of body weight daily per US Dietary Guidelines, though patients with chronic kidney disease should follow their healthcare provider's specific recommendations)
GLP-1s come in both injectable and oral forms